Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian breast cancer family registry

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 2, 2016, Pages 359-365

  Dite, Gillian S ^a   Macinnis, Robert J ^a,b   Bickerstaffe, Adrian ^a   Dowty, James G ^a   Allman, Richard ^c   Apicella, Carmel ^a   Milne, Roger L ^a,b   Tsimiklis, Helen ^a   Phillips, Kelly Anne ^a,d   Giles, Graham G ^a,b   Terry, Mary Beth ^e   Southey, Melissa C ^a   Hopper, John L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c Genetic Technologies Limited   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AUSTRALIA; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MIDDLE AGED; REGISTER; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; AUSTRALIA; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84957797662     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0838     Document Type: Article

References (39)

1. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 2013;15:R92.
2. Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, et al. Risk determination and prevention of breast cancer. Breast Cancer Res 2014;16:466.
3. Quante AS, Whittemore AS, Shriver T, Hopper JL, Strauch K, Terry MB. Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. J Natl Cancer Inst 2015;107.
4. Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, et al. The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer 2008;98:1457-66.
5. Antoniou AC, Pharoah PPD, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 2004; 91:1580-90.
6. Chen S, Wang W, Broman KW, Katki HA, Parmigiani G. BayesMendel: an Renvironment for Mendelian risk prediction. Stat Appl Genet Mol Biol 2004;3:Article 21.
7. Mazzola E, Chipman J, Cheng SC, Parmigiani G. Recent BRCAPRO upgrades significantly improve calibration. Cancer Epidemiol Biomarkers Prev 2014;23:1689-95.
8. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-58.
9. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies formodels projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999;91:1541-8.
10. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
11. Tyrer J, Duffy SW, Cuzick J. A breast cancer predictionmodel incorporating familial and personal risk factors. Stat Med 2004;23:1111-30.
12. MacInnis RJ, Bickerstaffe A, Apicella C, Dite GS, Dowty JG, Aujard K, et al. Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEA Centre. Br J Cancer 2013;109: 1296-301.
13. Stahlbom AK, Johansson H, Liljegren A, von Wachenfeldt A, Arver B. Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer. Fam Cancer 2012;11:33-40.
14. Laitman Y, Simeonov M, Keinan-Boker L, Liphshitz I, Friedman E. Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models. Genet Res 2013;95:174-7.
15. Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003;40:807-14.
16. Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res 2012;14:R144.
17. Pepe MS, Janes HE. Gauging the performance of SNPs, biomarkers, and clinical factors for predicting risk of breast cancer. J Natl Cancer Inst 2008;100:978-9.
18. Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, et al. Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 2015;107:djv036.
19. Dite GS, Mahmoodi M, Bickerstaffe A, Hammet F, Macinnis RJ, Tsimiklis H, et al. Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model. Breast Cancer Res Treat 2013;139:887-96.
20. Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst 2010;102:1618-27.
21. Gail MH. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 2008;100: 1037-41.
22. Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med 2010;362:986-93.
23. Gail MH. Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model. J Natl Cancer Inst 2009;101:959-63.
24. Comen E, Balistreri L, Gonen M, Dutra-Clarke A, Fazio M, Vijai J, et al. Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Res Treat 2011;127:479-87.
25. Brentnall AR, Evans DG, Cuzick J. Value of phenotypic and single-nucleotide polymorphism panel markers in predicting the risk of breast cancer. J Genet Syndr Gene Ther 2013;4:202.
26. Brentnall AR, Evans DG, Cuzick J. Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK. Br J Cancer 2014;110:827-8.
27. Vachon CM, Pankratz VS, Scott CG, Haeberle L, Ziv E, Jensen MR, et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 2015;107.
28. McCredie MR, Dite GS, Giles GG, Hopper JL. Breast cancer in Australian women under the age of 40. Cancer Causes Control 1998;9:189-98.
29. Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, et al. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003;95:448-57.
30. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6: R375-89.
31. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet 2013;45:353-61.
32. Hopper JL. Odds PER Adjusted standard deviation (OPERA): Comparing strengths of associations for risk factors measured on different scales, and across diseases and populations. Am J Epidemiol 2015;182: 863-7.
33. StataCorp. Stata statistical software, release 13. College Station, TX: Stata- Corp LP; 2013.
34. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst 2006;98:1204-14.
35. Chen J, Pee D, Ayyagari R, Graubard B, Schairer C, Byrne C, et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst 2006; 98:1215-26.
36. Severi G, Southey MC, English DR, Jung CH, Lonie A, McLean C, et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat 2014;148:665-73.
37. Amir E, Freedman OC, Seruga B, Evans DG. Assessingwomen at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-91.
38. Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol 1992;136:1138-47.
39. Hopper JL. Disease-specific prospective family study cohorts enriched for familial risk. Epidemiol Perspect Innov 2011;8:2.